Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:52:04 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



Q:EXAS - EXACT SCIENCES CORP - http://www.exactsciences.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
EXAS - Q2.058.58·59.000.258.85+0.060.12,018.9118,21716,72059.02  60.31  58.45100.77  56.0518:48:53Apr 1515 min RT 2¢

Recent Trades - Last 10 of 16720
Time ETExPriceChangeVolume
18:48:53Q58.950.1613
18:48:11Q58.850.062
18:47:15Q58.850.068
17:22:39Q58.990.203
17:17:12Q58.990.2025
16:03:36Q58.800.0173
16:02:28Q58.850.0629
16:02:27Q58.850.06183
16:02:10Q58.850.06200
16:01:46Q58.850.06340

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-15 06:00U:EXASNews ReleaseExact Sciences Names Aaron Bloomer as New Chief Financial Officer
2024-04-11 06:00U:EXASNews ReleaseExact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
2024-04-08 12:05U:EXASNews ReleaseExact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
2024-04-08 06:00U:EXASNews ReleaseExact Sciences Schedules First Quarter 2024 Earnings Call
2024-04-04 06:05U:EXASNews ReleaseExact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
2024-03-28 06:00U:EXASNews ReleaseExact Sciences Advances Development of Non-Endoscopic Oncoguard(TM) Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
2024-03-27 08:05U:EXASNews ReleaseExact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
2024-03-13 17:03U:EXASNews ReleaseThe New England Journal of Medicine Publishes Cologuard Plus(TM) Test Results from Pivotal BLUE-C Study
2024-03-07 07:59U:EXASNews ReleaseExact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
2024-02-26 06:00U:EXASNews ReleaseExact Sciences to Participate in March Investor Conference
2024-02-21 16:05U:EXASNews ReleaseExact Sciences Announces Fourth Quarter 2023 Results
2024-02-01 06:00U:EXASNews ReleaseExact Sciences Schedules Fourth Quarter 2023 Earnings Call
2024-01-07 16:30U:EXASNews ReleaseExact Sciences Announces Preliminary Fourth Quarter 2023 Results
2024-01-02 06:00U:EXASNews ReleaseExact Sciences to participate in J.P. Morgan Healthcare Conference
2023-12-07 08:05U:EXASNews ReleaseExact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings
2023-11-30 16:05U:EXASNews ReleaseExact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
2023-11-17 07:10U:EXASNews ReleaseExact Sciences Files Patent Infringement Lawsuit Against Geneoscopy
2023-11-01 16:05U:EXASNews ReleaseExact Sciences Announces Third-Quarter 2023 Results
2023-11-01 06:00U:EXASNews ReleaseExact Sciences to participate in November investor conferences
2023-10-22 15:00U:EXASNews ReleaseNext-Generation Cologuard ‚ ® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection